Efficacy and safety of adjustable balloons (ProACT) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study
Neurourology and Urodynamics Jul 19, 2019
Agrò EF, et al. - Through a multicentric retrospective study of the data from nine centers of male subjects with stress urinary incontinence (SUI) who underwent a ProACT device implantation for postoperative SUI and had a minimum follow-up of 24 months, experts assessed the efficiency and safety of the ProACT system. Two hundred and forty subjects reported the efficiency and safety. At 24 months, 29.6%, 37.5% and 32.9% of subjects were dry, improved and were considered failures, respectively. At 24 months, the baseline mean pad weight of 367 g was decreased to 123 g. A similar efficiency was exhibited on 152 patients by five-year follow-up. With the top complication observed as long-term balloon failure, the complication rate was calculated as 22.5%. Hence, for male postoperative SUI at both medium and long-term follow up, ProACT implantation demonstrated a safe and efficient treatment. At 24 months, 67.1% of cases were dry or improved while the majority of complications were low grade in nature.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries